Zavesca (miglustat)

**Product type:** Human Prescription Drug

**Active ingredient:** MIGLUSTAT

**Strength:** 100 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Actelion Pharmaceuticals US, Inc.

**Marketing category:** NDA (NDA021348)

**Pharmacologic class:** Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA]